InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Kaplan Myron, Director. Officer active across 1 companies, notably CorMedix Inc.. Cumulatively, 7 reports have been published. Total volume traded: €257k. The latest transaction was disclosed on 17 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€17,9185,000 shares@ €3.58370.0019% mcap7.0% of flow
Common Stock
SEC:0001213900-22-027983:0·
Ideal exit: 11 Feb 2023 (T+270)
020,000 shares0
Common Stock
SEC:0001213900-21-067924·
020,000 shares0
Common Stock
SEC:0001213900-21-067924:0·
€45,22110,000 shares@ €4.522137.8% of flow
Common Stock
SEC:0001213900-21-060879·
Ideal exit: 13 Aug 2022 (T+270)
€45,22110,000 shares@ €4.52210.0049% mcap17.6% of flow
Common Stock
SEC:0001213900-21-060879:0·
Ideal exit: 13 Aug 2022 (T+270)
€74,42515,000 shares@ €4.961662.2% of flow
Common Stock
SEC:0001213900-21-027991·
Ideal exit: 11 Feb 2022 (T+270)
€74,42515,000 shares@ €4.96160.0081% mcap28.9% of flow
Common Stock
SEC:0001213900-21-027991:0·
Ideal exit: 11 Feb 2022 (T+270)
7 of 7 declarations
About Kaplan Myron
Myron Kaplan is a Board Member at CorMedix Inc. He brings valuable expertise in corporate governance and strategy. His role involves overseeing the company's operations and ensuring that shareholder interests are protected. Kaplan plays a key role in strategic decision-making and guiding the company towards its long-term goals.
